Wang J, Yang D, Yu H, Jin J, Nie Y, Zhang S
Nat Commun. 2025; 16(1):2288.
PMID: 40055333
PMC: 11889272.
DOI: 10.1038/s41467-025-57538-7.
Giarolla J, Holdaway K, Nazari M, Aiad L, Sarkar B, Georg G
Future Med Chem. 2025; 17(5):607-627.
PMID: 40034037
PMC: 11901406.
DOI: 10.1080/17568919.2025.2463868.
Pitolli C, Marini A, Sette C, Pagliarini V
Cell Death Differ. 2024; 32(3):371-381.
PMID: 39533070
PMC: 11893892.
DOI: 10.1038/s41418-024-01413-3.
Ali G, Ewida M, Elmetwali A, Ewida H, George R, Mahmoud W
RSC Adv. 2024; 14(47):34537-34555.
PMID: 39479486
PMC: 11520566.
DOI: 10.1039/d4ra06500j.
Karimbayli J, Pellarin I, Belletti B, Baldassarre G
Mol Cancer. 2024; 23(1):135.
PMID: 38951876
PMC: 11218289.
DOI: 10.1186/s12943-024-02043-6.
Slower CDK4 and faster CDK2 activation in the cell cycle.
Zhang W, Liu Y, Jang H, Nussinov R
Structure. 2024; 32(8):1269-1280.e2.
PMID: 38703777
PMC: 11316634.
DOI: 10.1016/j.str.2024.04.012.
Unveiling the noncanonical activation mechanism of CDKs: insights from recent structural studies.
Li T, Tang H, Tsai K
Front Mol Biosci. 2023; 10:1290631.
PMID: 38028546
PMC: 10666765.
DOI: 10.3389/fmolb.2023.1290631.
Insights from the protein interaction Universe of the multifunctional "Goldilocks" kinase DYRK1A.
Ananthapadmanabhan V, Shows K, Dickinson A, Litovchick L
Front Cell Dev Biol. 2023; 11:1277537.
PMID: 37900285
PMC: 10600473.
DOI: 10.3389/fcell.2023.1277537.
Activation Loop Plasticity and Active Site Coupling in the MAP Kinase, ERK2.
Pegram L, Riccardi D, Ahn N
J Mol Biol. 2023; 435(23):168309.
PMID: 37806554
PMC: 10676806.
DOI: 10.1016/j.jmb.2023.168309.
Protein structure prediction with in-cell photo-crosslinking mass spectrometry and deep learning.
Stahl K, Graziadei A, Dau T, Brock O, Rappsilber J
Nat Biotechnol. 2023; 41(12):1810-1819.
PMID: 36941363
PMC: 10713450.
DOI: 10.1038/s41587-023-01704-z.
Allosteric regulation and inhibition of protein kinases.
Mingione V, Paung Y, Outhwaite I, Seeliger M
Biochem Soc Trans. 2023; 51(1):373-385.
PMID: 36794774
PMC: 10089111.
DOI: 10.1042/BST20220940.
Emerging approaches to CDK inhibitor development, a structural perspective.
Hope I, Endicott J, Watt J
RSC Chem Biol. 2023; 4(2):146-164.
PMID: 36794018
PMC: 9906319.
DOI: 10.1039/d2cb00201a.
Dynamics of protein kinases and pseudokinases by HDX-MS.
Sheetz J, Lemmon M, Tsutsui Y
Methods Enzymol. 2022; 667:303-338.
PMID: 35525545
PMC: 9148214.
DOI: 10.1016/bs.mie.2022.03.037.
Protein Flexibility and Dissociation Pathway Differentiation Can Explain Onset of Resistance Mutations in Kinases.
Shekhar M, Smith Z, Seeliger M, Tiwary P
Angew Chem Int Ed Engl. 2022; 61(28):e202200983.
PMID: 35486370
PMC: 9256798.
DOI: 10.1002/anie.202200983.
Effect of pH on the structure and function of cyclin-dependent kinase 6.
Yousuf M, Shamsi A, Anjum F, Shafie A, Islam A, Rizwanul Haque Q
PLoS One. 2022; 17(2):e0263693.
PMID: 35148332
PMC: 8836317.
DOI: 10.1371/journal.pone.0263693.
Mutations in the helix αC of the catalytic domain from the EGFR affect its activity in cervical cancer cell lines.
Valle-Mendiola A, Bustos-Rodriguez R, Dominguez-Melendez V, Zerecero-Carreon O, Gutierrez-Hoya A, Weiss-Steider B
Oncol Lett. 2022; 23(2):71.
PMID: 35069880
PMC: 8756430.
DOI: 10.3892/ol.2022.13191.
CDK9: A Comprehensive Review of Its Biology, and Its Role as a Potential Target for Anti-Cancer Agents.
Anshabo A, Milne R, Wang S, Albrecht H
Front Oncol. 2021; 11:678559.
PMID: 34041038
PMC: 8143439.
DOI: 10.3389/fonc.2021.678559.
Cyclin-Dependent Kinases (CDK) and Their Role in Diseases Development-Review.
Lukasik P, Zaluski M, Gutowska I
Int J Mol Sci. 2021; 22(6).
PMID: 33805800
PMC: 7998717.
DOI: 10.3390/ijms22062935.
Allostery governs Cdk2 activation and differential recognition of CDK inhibitors.
Majumdar A, Burban D, Muretta J, Thompson A, Engel T, Rasmussen D
Nat Chem Biol. 2021; 17(4):456-464.
PMID: 33526892
PMC: 7990704.
DOI: 10.1038/s41589-020-00725-y.
Insight into glycogen synthase kinase-3β inhibitory activity of phyto-constituents from : in silico studies.
Iwaloye O, Elekofehinti O, Oluwarotimi E, Kikiowo B, Fadipe T
In Silico Pharmacol. 2020; 8(1):2.
PMID: 32968615
PMC: 7487069.
DOI: 10.1007/s40203-020-00054-x.